Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07662057
PHASE1

A Study to Investigate the Safety, Tolerability, and PK of AB102 in Healthy Participants

Sponsor: Arcus Biosciences, Inc.

View on ClinicalTrials.gov

Summary

The purpose of this study is assess the safety and tolerability of AB102 and characterize the pharmacokinetics (PK) profile of AB102 after single and multiple ascending oral dose(s).

Official title: A Double-Blind, Randomized, Placebo-Controlled, Combined Single Ascending Dose and Multiple Ascending Dose First-In-Human Study to Investigate the Safety, Tolerability, and Pharmacokinetics of AB102 in Healthy Participants

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

130

Start Date

2026-07-09

Completion Date

2026-12

Last Updated

2026-08-25

Healthy Volunteers

Yes

Interventions

DRUG

AB102

Administered orally as specified in the treatment arm

OTHER

Placebo

Administered orally as specified in the treatment arm

Locations (1)

Research Site

Groningen, Netherlands